Table 2.
CpG Sites * | ||||||||
---|---|---|---|---|---|---|---|---|
Chromosome | BP Start |
BP Width |
Functional Annotation |
Gene Symbol |
FDR | Total | Hyper | Hypo |
4 | 184,908,253 | 766 | Distal intergenic | LINC01093 | 1.67 × 10−9 | 11 | 0 | 10 |
6 | 291,686 | 911 | Promoter (≤1 kb) | DUSP22 | 1.76 × 10−9 | 8 | 0 | 8 |
11 | 6,291,624 | 888 | Distal intergenic | CCKBR | 1.76 × 10−9 | 7 | 0 | 7 |
17 | 40,274,523 | 289 | Promoter (≤1 kb) | WIPF2 | 1.02 × 10−7 | 7 | 0 | 6 |
1 | 42,384,283 | 365 | Intron | RIMKLA | 2.23 × 10−7 | 8 | 0 | 8 |
7 | 69,064,092 | 87 | Distal intergenic | CT66 | 3.26 × 10−7 | 4 | 0 | 4 |
2 | 48,132,739 | 315 | Intron | FOXN2 | 3.26 × 10−7 | 7 | 0 | 7 |
17 | 80,408,535 | 394 | Intron | RNF213-AS1 | 3.30 × 10−7 | 8 | 0 | 6 |
21 | 47,532,059 | 275 | Distal intergenic | PRMT2 | 6.89 × 10−7 | 5 | 0 | 4 |
12 | 123,319,893 | 165 | Exon | SBNO1 | 8.02 × 10−7 | 5 | 0 | 4 |
14 | 93,698,773 | 172 | Intron | UNC79 | 8.02 × 10−7 | 3 | 0 | 3 |
11 | 123,430,574 | 376 | Promoter (≤1 kb) | GRAMD1B | 8.67 × 10−7 | 6 | 0 | 6 |
1 | 161,008,461 | 366 | Intron | F11R | 8.90 × 10−7 | 8 | 3 | 3 |
12 | 123,750,781 | 84 | Promoter (≤1 kb) | ATP6V0A2 | 9.13 × 10−7 | 3 | 0 | 3 |
5 | 170,814,528 | 309 | Distal intergenic | GABRP | 9.13 × 10−7 | 8 | 0 | 8 |
19 | 2,163,592 | 241 | Promoter (≤1 kb) | DOT1L | 1.01 × 10−6 | 4 | 0 | 4 |
11 | 9,697,192 | 238 | Intron | SWAP70 | 1.03 × 10−6 | 2 | 1 | 1 |
17 | 53,828,262 | 254 | Intron | KIF2B | 1.03 × 10−6 | 6 | 0 | 4 |
19 | 35,645,555 | 158 | Promoter (1–2 kb) | ETV2 | 1.03 × 10−6 | 8 | 0 | 6 |
16 | 56,228,384 | 361 | Promoter (2–3 kb) | GNAO1 | 1.87 × 10−6 | 9 | 0 | 7 |
3 | 9,932,179 | 145 | Promoter (1–2 kb) | IL17RC | 1.93 × 10−6 | 6 | 0 | 4 |
2 | 48,844,762 | 307 | Intron | STON1-GTF2A1L | 2.31 × 10−6 | 6 | 0 | 5 |
22 | 44,422,011 | 189 | Distal intergenic | LINC01656 | 2.46 × 10−6 | 5 | 3 | 2 |
16 | 10,837,596 | 110 | Distal intergenic | TVP23A | 2.71 × 10−6 | 8 | 0 | 6 |
6 | 85,823,948 | 269 | Distal intergenic | SNHG5 | 4.21 × 10−6 | 4 | 0 | 4 |
11 | 117,352,729 | 211 | Promoter (≤1 kb) | CEP164 | 5.14 × 10−6 | 4 | 0 | 4 |
14 | 105,287,325 | 103 | Intron | BRF1 | 5.46 × 10−6 | 3 | 0 | 3 |
19 | 37,825,319 | 254 | Promoter (2–3 kb) | LOC644554 | 6.11 × 10−6 | 6 | 0 | 6 |
10 | 133,938,603 | 291 | Distal intergenic | FRG2B | 6.18 × 10−6 | 5 | 0 | 3 |
3 | 15,469,026 | 292 | Intron | COLQ | 8.95 × 10−6 | 6 | 0 | 4 |
19 | 49,222,966 | 288 | Distal intergenic | TRPM4 | 1.16 × 10−5 | 4 | 0 | 3 |
11 | 116,658,839 | 232 | Distal intergenic | LINC02702 | 3.16 × 10−5 | 5 | 0 | 5 |
7 | 95,064,396 | 79 | Intron | PPP1R9A | 3.97 × 10−5 | 5 | 0 | 4 |
16 | 1,199,498 | 27 | Intron | CACNA1H | 4.70 × 10−5 | 2 | 0 | 2 |
9 | 130,533,824 | 27 | Distal intergenic | FUBP3 | 6.41 × 10−5 | 4 | 0 | 2 |
16 | 1,031,442 | 17 | Distal intergenic | SSTR5-AS1 | 7.07 × 10−5 | 2 | 0 | 2 |
16 | 66,638,395 | 205 | Promoter (1–2 kb) | CMTM4 | 1.27 × 10−4 | 6 | 0 | 4 |
16 | 12,070,415 | 274 | Intron | SNX29 | 1.42 × 10−4 | 5 | 0 | 4 |
19 | 44,259,187 | 10 | Promoter (≤1 kb) | ZNF233 | 1.44 × 10−4 | 2 | 0 | 2 |
10 | 101,282,815 | 69 | Distal intergenic | LINC02681 | 2.29 × 10−4 | 2 | 2 | 0 |
12 | 111,126,997 | 143 | Intron | CUX2 | 6.16 × 10−4 | 4 | 1 | 1 |
1 | 166,958,580 | 4 | Intron | ILDR2 | 0.001 | 2 | 0 | 2 |
3 | 88,198,600 | 152 | Distal intergenic | C3orf38 | 0.002 | 4 | 0 | 1 |
11 | 368,564 | 75 | Promoter (≤1 kb) | B4GALNT4 | 0.003 | 5 | 0 | 2 |
2 | 8,597,158 | 31 | Distal intergenic | LINC01814 | 0.003 | 3 | 0 | 2 |
2 | 1846836 | 18 | Intron | MYT1L | 0.004 | 2 | 0 | 2 |
BP, base pair; BTEX, benzene, toluene, ethylbenzene, and xylenes; FDR, false discovery rate. BP Start denotes the 5’ most base pair position within each region based on genome build hg38. BP Width is the number of base pairs over which each region spans. Functional Annotation corresponds to the annotation category assigned to each region by CHiPseeker. Gene Symbol is the official gene symbol for the gene nearest to the region identified by CHiPseeker. False discovery rate is the adjusted p-value for the region as determined by comb-p. * The total number of CpG sites within each DMR, and the subset with single CpG site nominal p-values < 0.05, where increasing BTEX exposure was associated with hyper- and hypo-methylation.